SGP
{"sector":"Financial","industry":"Exchange Traded Fund","symbol":"SGOL","company_name":"Aberdeen Standard Physical Swiss Gold Shares ETF","exchange":"NYSEARCA"}SGP Articles
Reuters: Banks paid out billions of dollars in bonuses last year while losing money. Reuters: The US closed its car “clunkers” program just as it began as funds ran out. Reuters: ...
Published:
Last Updated:
So far we have three DJIA components with earnings out. DuPont (NYSE: DD), Merck & Co. (NYSE: MRK), United Technologies (NYSE: UTX) have all posted earnings. So far there are no train wrecks...
Published:
Last Updated:
If the rumor mill has any truth to it, then Allergan Inc. (NYSE: GSK) may by the next biotech takeover target. There is roughly $150 billion in new equity investor capital that can be put to work...
Published:
Last Updated:
Merck (MRK) is merging with Schering-Plough (SGP) in a deal that the companies say is worth $41.1 billion. In reality, Merck is making an acquisition. Its shares will be the currency to compete the...
Published:
Last Updated:
We compiled a list of the equity holdings of the Bill & Melinda Gates Foundation and for Bill Gates’ personal investment vehicle Cascade Investment. These are as of December 31, 2008 and we...
Published:
Last Updated:
There may be some speculation that drug giant Pfizer Inc. (NYSE: PFE) is looking at expansion through acquisitions. The FT reported that the world’s largest pharmaceutical company is willing to...
Published:
Last Updated:
These are the top analyst downgrade calls we are seeing this Friday morning with two hours to the open: Adobe Systems (ADBE) Cut to Sell at UBS. Agrium (AGU) Cut to Hold at Canaccord. Cummins Inc....
Published:
The evidence that sales at many companies are struggling and that employment will suffer are almost everywhere. Recently, a division of GMAC said it would let 5,000 people go. According to MSNBC,...
Published:
Last Updated:
Merck (MRK) and Schering-Plough (SGP) make two of the most widely sold drugs in the world. One is cholesterol drug Zetia. Another is a related drug called Vytorin. The sales of the treatments topped...
Published:
Last Updated:
These are some of the top upgrades or positive analyst calls we have seen this Tuesday morning in early pre-market trading hours: eHealth (NASDAQ: EHTH) Raised to Perform from Underperform at...
Published:
The profit-mongering Big Pharma companies don’t want the FDA to take so long approving their drugs. It cuts into profits and delays their chances of making money on new blockbuster treatments....
Published:
Superior Offshore (DEEP) Company warns of liquidity problems. Down to $1.20 from 52-week high of $19.58. Medarex (MEDX) Pfizer ends joint drug trial. Sells off to $7.44 from 52-week high of $18.23....
Published:
According to Reuters, US car sales for March are likely to be off sharply. Reuters writes that Microsoft (MSFT) will not raise its bid for Yahoo! (YHOO) Reuters reports that UBS (UBS) will take a...
Published:
The largest losers among the big companies in the S&P 500 for the first quarter were: Microsoft (MSFT) down 21.6%, Google (GOOG) down 36.7%, Apple (AAPL) down 27.8%, Intel (INTC) down 22%,...
Published:
Schering-Plough (SGP) Bad news on key cholesterol drug marketed with Merck. Shares fall to $14 from 52-week high of $33.81. Merck (MRK) Pulled down for the same reason. Sells off to $36.82 from...
Published: